Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer

doi:10.4329/wjr.v9.i3.134

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7397)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

443

WORD

245

HTML

2287

Figures (1-4)

180

Tables (1-3)

170

Sum=3325

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

831

Download

1097

Sum=1928

Publishing Process of This Article

Item

Count

Browse

764

Download

1380

Sum=2144

Mar 28, 2017 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Radiol. Mar 28, 2017; 9(3): 134-142
Published online Mar 28, 2017. doi: 10.4329/wjr.v9.i3.134

Open in New Tab Full Size Figure Download Figure

Figure 1 Representative 1. 5T magnetic resonance imaging/magnetic resonance spectroscopic imaging in a 58-year-old patient with prostate specific antigen 96.53 ng/mL, clinical stage T3 and surgical Gleason score 4 + 5. A: Axial T2-weighted image and overlaid point-resolved spectroscopic box indicating excitation region selected and 3D MRSI demonstrating three suspicious voxels marked with asterisks; B: ¹⁸F-FDG-PET/CT fusion image shows a focal uptake in the left prostate; C: Whole-mount step-section histopathology after radical prostatectomy shows a large cancer in the left prostate. MRSI: Magnetic resonance spectroscopic imaging; ¹⁸F-FDG-PET/CT: ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography.

Open in New Tab Full Size Figure Download Figure

Figure 2 Representative 1. 5T magnetic resonance imaging/magnetic resonance spectroscopic imaging in a 64-year-old patient with prostate specific antigen 4.9 ng/mL, clinical stage T3 and surgical Gleason score 4 + 3. A: Axial T2-weighted image and overlaid point-resolved spectroscopic box indicating excitation region selected and 3D MRSI demonstrating ten suspicious voxels marked with asterisks; B: ¹⁸F-FDG-PET/CT fusion image shows no focal uptake in the prostate; C: Whole-mount step-section histopathology after radical prostatectomy shows a large cancer extending from medial to right side of the prostate. MRSI: Magnetic resonance spectroscopic imaging; ¹⁸F-FDG-PET/CT: ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography.

Open in New Tab Full Size Figure Download Figure

Figure 3 Scatter plots demonstrating the relationships between proton magnetic resonance spectroscopic imaging and ¹⁸F-fluorodeoxyglucose positron emission tomography parameters (n = 22). PET: Positron emission tomography.

Open in New Tab Full Size Figure Download Figure

Figure 4 Box plots demonstrating the relationships between surgical Gleason score and imaging parameters (n = 22).

Citation: Shukla-Dave A, Wassberg C, Pucar D, Schöder H, Goldman DA, Mazaheri Y, Reuter VE, Eastham J, Scardino PT, Hricak H. Multimodality imaging using proton magnetic resonance spectroscopic imaging and ¹⁸F-fluorodeoxyglucose-positron emission tomography in local prostate cancer. World J Radiol 2017; 9(3): 134-142
URL: https://www.wjgnet.com/1949-8470/full/v9/i3/134.htm
DOI: https://dx.doi.org/10.4329/wjr.v9.i3.134